Linical Co Ltd
TSE:2183

Watchlist Manager
Linical Co Ltd Logo
Linical Co Ltd
TSE:2183
Watchlist
Price: 330 JPY Market Closed
Market Cap: 7.5B JPY
Have any thoughts about
Linical Co Ltd?
Write Note

Linical Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Linical Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Linical Co Ltd
TSE:2183
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Additional Paid In Capital
ÂĄ6.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
C
Chiome Bioscience Inc
TSE:4583
Additional Paid In Capital
ÂĄ1.5B
CAGR 3-Years
-21%
CAGR 5-Years
-24%
CAGR 10-Years
-8%
Medinet Co Ltd
TSE:2370
Additional Paid In Capital
ÂĄ1.3B
CAGR 3-Years
34%
CAGR 5-Years
-4%
CAGR 10-Years
-16%
CellSource Co Ltd
TSE:4880
Additional Paid In Capital
ÂĄ1.3B
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WDB coco Co Ltd
TSE:7079
Additional Paid In Capital
ÂĄ280m
CAGR 3-Years
1%
CAGR 5-Years
41%
CAGR 10-Years
N/A
No Stocks Found

Linical Co Ltd
Glance View

Market Cap
7.5B JPY
Industry
Life Sciences Tools & Services

Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. The company is headquartered in Osaka, Osaka-Fu and currently employs 845 full-time employees. The company went IPO on 2008-10-27. The firm operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.

Intrinsic Value
1 016.58 JPY
Undervaluation 68%
Intrinsic Value
Price

See Also

Back to Top